Integration of 2-deoxy-2-[18F] fluoro-d-glucose PET/CT into clinical management of patients with Wegener's granulomatosis

Annals of Nuclear Medicine

Volumn 27, Issue 10, 2013, Pages 907-915

  Ozmen, Ozlem ^a   Tatci, Ebru ^a   Gokcek, Atila ^b   Koksal, Deniz ^b   Dadali, Yeliz ^b   Ozaydin, Esra ^b   Arslan, Nuri ^c  

^a Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital   (Turkey)

^b Ataturk Chest Disease and Thoracic Surgery Education and Research Hospital Ankara   (Turkey)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

PET CT; Vasculitis; Wegener's granulomatosis

Indexed keywords

CREATININE; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; EAR DISEASE; EVALUATION AND FOLLOW UP; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LUNG DISEASE; MALE; MIDDLE AGED; MULTIPLE PULMONARY NODULES; NOSE DISEASE; PET-CT SCANNER; PHARYNX DISEASE; PRIORITY JOURNAL; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINARY EXCRETION; WEGENER GRANULOMATOSIS;

ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; WEGENER GRANULOMATOSIS;

EID: 84891482271     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-013-0769-6     Document Type: Article

References (20)

1. Woywodt A, Matteson EL. Wegener's granulomatosis - probing the untold past of the man behind the eponym. Rheumatology (Oxford). 2006;45(10):1303-6. (Pubitemid 44542075)
2. Frankel SK, Cosgrove GP, Fischer A, Meehan RT, Brown KK. Update in the diagnosis and management of pulmonary vasculitis. Chest. 2006;129(2):452-65. (Pubitemid 43289869)
3. Fries JF, Hunder GG, Bloch DA, Michel BA, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990;33(8):1135-6. (Pubitemid 20273299)
4. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998;53(3):743-53. (Pubitemid 28124291)
5. Choi HK, Liu S, Merkel PA, Colditz GA, Niles JL. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J Rheumatol. 2001;28(7):1584-90. (Pubitemid 32660632)
6. Pretorius ES, Stone JH, Hellmann DB, Fishman EK. Wegener's granulomatosis: spectrum of CT findings in diagnosis, disease progression, and response to therapy. Crit Rev Diagn Imaging. 2000;41(4):279-313.
7. Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med. 2004;117(1):39-50. (Pubitemid 38798019)
8. Frankel SK, Cosgrove GP, Fischer A, Meehan RT, Brown KK. Update in the diagnosis and management of pulmonary vasculitis. Chest. 2006;129(2):452-65. (Pubitemid 43289869)
9. Levin A, Kasem S, Mader R, Naparstek Y, Friedman G, Ben-Yehuda A. Wegener granulomatosis with back pain, periaortitis, and dural inflammation developing while receiving monthly cyclophosphamide. J Clin Rheumatol. 2006;12(6):294-7. (Pubitemid 44915329)
10. Ito K, Minamimoto R, Yamashita H, Yoshida S, Morooka M, Okasaki M. Evaluation of Wegener's granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Ann Nucl Med. 2012.
11. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33(8):1101-7. (Pubitemid 20273294)
12. Bleeker-Rovers CP, Bredie SJ, van der Meer JW, Corstens FH, Oyen WJ. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med. 2003;61(10):323-9. (Pubitemid 39089433)
13. Walter MA, Melzer RA, Schindler C, Müller-Brand J, Tyndall A, Nitzsche EU. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging. 2005;32(6):674-81. (Pubitemid 40897490)
14. Fuchs M, Briel M, Daikeler T, Walker UA, Rasch H, Berg S. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging. 2012;39(2):344-53.
15. Beggs AD, Hain SF. F-18 FDG-positron emission tomographic scanning and Wegener's granulomatosis. Clin Nucl Med. 2002;27(10):705-6. (Pubitemid 38295175)
16. Lapraik C, Watts R, Bacon P, Carruthers D, Chakravarty K, D'Cruz D. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford). 2007;46(10):1615-6.
17. Fries JF, Hunder GG, Bloch DA, Michel BA, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990;33(8):1135-6. (Pubitemid 20273299)
18. Maranhão AS, Chen VG, Rossini BA, Testa JR, Penido Nde O. Mastoiditis and facial paralysis as initial manifestations of Wegener's granulomatosis. Braz J Otorhinolaryngol. 2012;78(2):80-6.
19. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187-92. (Pubitemid 24065492)
20. Blockmans D, Baeyens H, Van Loon R, Lauwers G, Bobbaers H. Periaortitis and aortic dissection due to Wegener's granulomatosis. Clin Rheumatol. 2000;19(2):161-4. (Pubitemid 30236151)